References
- Mishra AC, Chadha MS, Choudhary ML, Potdar VA. Pandemic influenza (H1N1) 2009 is associated with severe disease in India. PLoS ONE 2010; 5:e10540; http://dx.doi.org/10.1371/journal.pone.0010540; PMID: 20479875
- Tandale BV, Pawar SD, Gurav YK, Chadha MS, Koratkar SS, Shelke VN, et al. Seroepidemiology of pandemic influenza A (H1N1) 2009 virus infections in Pune, India. BMC Infect Dis 2010; 10:255; http://dx.doi.org/10.1186/1471-2334-10-255; PMID: 20738878
- Tandale BV, Pawar SD, Mishra AC. Immunogenicity and safety of pandemic H1N1 2009 vaccine among adults in field use, India. Vaccine 2012; 30:2043 - 4; http://dx.doi.org/10.1016/j.vaccine.2011.10.008; PMID: 22001279
- World Health Organization. Manual on animal influenza diagnosis and surveillance. WHO/CDS/CSR/NCS; 2002.
- Sanofi Pasteur. Panenza Pandemic influenza vaccine (H1N1) (split-virion, inactivated). Public Assessment Report. FR/H/447/01-02/DC. Available at: http://afssaps-prd.afssaps.fr/html/par eu/20091113 fr447 panenza par.pdf (accessed on 25.01.10).
- Lai YC, Yang KC, Hsieh SM, Yao CA, Lee LT, Huang KC. Persistence of immunogenicity of a monovalent influenza virus A/H1N1 2009 vaccine in healthy volunteers. Clin Vaccine Immunol 2012; 19:429 - 35; http://dx.doi.org/10.1128/CVI.05528-11; PMID: 22258708
- Crum-Cianflone NF, Iverson E, Defang G, Blair PJ, Eberly LE, Maguire J, et al. Durability of antibody responses after receipt of the monovalent 2009 pandemic influenza A (H1N1) vaccine among HIV-infected and HIV-uninfected adults. Vaccine 2011; 29:3183 - 91; http://dx.doi.org/10.1016/j.vaccine.2011.02.040; PMID: 21371580
- Chan KH, To KK, Hung IF, Zhang AJ, Chan JF, Cheng VC, et al. Differences in antibody responses of individuals with natural infection and those vaccinated against pandemic H1N1 2009 influenza. Clin Vaccine Immunol 2011; 18:867 - 73; http://dx.doi.org/10.1128/CVI.00555-10; PMID: 21411604
- Wang M, Yuan J, Li T, Liu Y, Wu J, Di B, et al. Antibody dynamics of 2009 influenza A (H1N1) virus in infected patients and vaccinated people in China. PLoS ONE 2011; 6:e16809; http://dx.doi.org/10.1371/journal.pone.0016809; PMID: 21347418
- Moran JJ, Rose WE, Darga AJ, Rohde KA, Hayney MS. Persistence of influenza vaccine-induced antibodies in lung transplant patients between seasons. Transpl Infect Dis 2011; 13:466 - 70; http://dx.doi.org/10.1111/j.1399-3062.2011.00654.x; PMID: 21615847
- Song JY, Cheong HJ, Hwang IS, Choi WS, Jo YM, Park DW, et al. Long-term immunogenicity of influenza vaccine among the elderly: Risk factors for poor immune response and persistence. Vaccine 2010; 28:3929 - 35; http://dx.doi.org/10.1016/j.vaccine.2010.03.067; PMID: 20394719